Park Square has placed Daniel Orlando as Chief Executive Officer at Alcresta Therapeutics.
| less than a minute read
Alcresta Therapeutics Announces Appointment of Daniel Orlando as Chief Executive Officer
Get in touch
Get in touch
Alcresta Therapeutics Inc., a leading commercial-stage company focused on developing and commercializing novel, enzyme-based products, announced the appointment of Daniel Orlando as its Chief Executive Officer (CEO) and member of the Board of Directors effective June 17, 2019.
Get in touch
Get in touch
/Passle/58a5cb8db00e8110e83aa395/MediaLibrary/Images/2026-11-06-17-39-37-187-6aee10d9e051d7ffd7756b19.jpeg)
/Passle/58a5cb8db00e8110e83aa395/MediaLibrary/Images/2026-09-29-16-59-13-899-6abbee61460fb9469a25b973.jpg)
/Passle/58a5cb8db00e8110e83aa395/MediaLibrary/Images/2026-10-21-12-53-31-969-6ad8b5cb057433a11d528afb.jpg)
/Passle/58a5cb8db00e8110e83aa395/SearchServiceImages/2026-10-19-20-59-27-876-6ad684af780cfbe7accbf179.jpg)